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Central nervous system tuberculosis is a rare form of disease that carries the
high mortality and the risk of permanent neurologic sequelae if not recognized
early. Clinical, laboratory and radiologic manifestations are usually nonspecif-
ic, thus postponing establishment of correct diagnosis and initiation of treat-
ment. We report a child with central nervous system tuberculosis, which mani-
fested with nontypical laboratory findings, as well as with the rare form of mil-
iary intracranial tuberculomas. Signs of active tuberculosis outside the central
nervous system in combination with insidious course of disease raised a suspi-
cion on tuberculosis. Therefore, antituberculous therapy was initiated promptly,
and the patient recovered completely, without permanent neurologic sequelae.
Prikaz bolesnika
Tuberkuloza sredi{njeg ` iv~anog sustava je rijedak oblik bolesti s visokom smrt-
nosti i rizikom trajnih neurolo{kih posljedica, ako se ne prepozna na vrijeme.
Klini~ke, laboratorijske i radiolo{ke manifestacije su obi~no nespecifi~ne, {to
odga|a dono{enje ispravne dijagnoze i po~etak lije~enja. U radu je prikazano
dijete s tuberkulozom sredi{njeg `iv~anog sustava koja se manifestirala neti-
pi~nim laboratorijskim nalazima i rijetkim milijarnim intrakranijskim tuberku-
lomima. Znakovi aktivne tuberkuloze izvan sredi{njeg ` iv~anog sustava u kom-
binaciji s prikrivenim tijekom bolesti izazvali su sumnju na tuberkulozu. Anti-
tuberkulozno lije~enje je odmah zapo~eto, a bolesnica se oporavila u potpuno-
sti, bez trajnih neurolo{kih posljedica.
Introduction
Central nervous system (CNS) tuberculosis (TB) is an
uncommon form of disease, which develops in around 4 %
of children with TB, but remains the most devastating
form of disease, carrying high mortality and a distressing
level of neurological morbidity [1]. Since clinical, labora-
tory and radiologic manifestations of CNS TB are nonspe-
cific, early recognition of the disease is a challenge.
However, it is of paramount importance because the clini-
cal outcome depends greatly upon the stage at which ther-
apy is initiated [2]. 
Here we report a case of CNS TB with rare form of
miliary intracranial tuberculomas and discuss the possible
clues for early diagnosis. 
Case presentation
A 10-year-old girl presented with a 1-month history of
dry cough, occasional low-grade fever, diarrhea, abdomi-
nal pain and weight loss of 4 kg. She was examined few
times at emergency department when no abnormalities in
physical examination were noticed. Laboratory findings
showed elevated erythrocyte sedimentation rate (65 – 85
mm/h), normal level of C-reactive protein, unremarkable
complete blood count and mildly elevated transaminases
(aspartate transaminase 85 IU/L and alanine transaminase
70 IU/L). In the fourth week of disease high temperature
appeared, with drowsiness, headache and photophobia, so
the girl was admitted to hospital.
She was previously healthy, regularly vaccinated as
provided by the Croatian National Immunization Program.
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Figure 1. Initial chest x-ray shows diffuse interstitial nodular lesions
Slika 1. Inicijalni radiogram prsnog ko{a pokazuje difuzne intersticijske nodularne lezije
Figure 2. Brain MRI performed on hospital day 4 shows multiple tiny lesions most prominent in cerebellum, but also present in the cere-
brum and brainstem
Slika 2. MR mozga u~injen 4. dan hospitalizacije pokazuje multiple sitne lezije najizra`enije u malom mozgu, koje su prisutne i u ve-
likom mozgu i mo`danom deblu
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Figure 3. Initial funduscopic examination reveals disseminated chorioretinitis of both eyes
Slika 3. Inicijalni pregled fundusa oka pokazuje diseminirani korioretinitis oba oka
Figure 4. Control chest x-ray 3 weeks after initiation of antituberculous therapy shows almost complete resolution of infiltrates
Slika 4. Kontrolni radiogram prsnog ko{a nakon po~etka primjene antituberkulotske terapije pokazuje gotovo potpuni nestanak infiltrata
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According to her mother's statement, the contacts were
healthy, although we later found out the grandmother was
in observation because of lung infiltrate with hilar lym-
phadenopathy.
On admission neurologic examination revealed nuchal
rigidity, but no focal neurologic deficits were detected. La-
boratory tests showed similar findings as previously men-
tioned. Because of the dry cough in anamnesis, chest x-ray
was performed on admission and revealed bilateral nodu-
lar infiltrates, highly suggestive of miliary TB (Figure 1).
Lumbar puncture demonstrated moderate pleocytosis
of 270 white cells/μL (neutrophils 55 %), mildly elevated
protein level (0.83 g/L) and cerebrospinal fluid (CSF)/
serum glucose ratio of 0.35. The patient was immediately
started on antituberculous treatment with isoniazid, ri-
fampicin, ethambutol and pyrazinamide. Dexamethasone
was also added as adjunctive therapy. Lumbar puncture
was repeated three days later, when antituberculous thera-
py was already initiated. Acid-fast staining, culture and
polymerase chain reaction (PCR) for Mycobacterium tu-
berculosis remained negative from both CSF samples. The
magnetic resonance imaging (MRI) of brain demonstrated
multiple, contrast enhanced tiny nodules in cerebellum,
cerebrum and brain stem, without signs of basal meningi-
tis. This finding highly suggested the miliary pattern of
brain tuberculomas (Figure 2).
Active searching for other signs of active TB outside
the CNS revealed disseminated chorioretinitis of both eyes
(Figure 3).
Our struggle to detect mycobacteria from other sam-
ples beside the CSF (i.e. bronchoalveolar lavage fluid,
urine, stool) unfortunately wasn't successful. Only blood
IFN-γ releasing assay (IGRA) came positive. Although eti-
ologic diagnosis wasn't confirmed, there was significant
clinical and radiologic improvement on treatment (Figures
4, 5). Repeated lumbar puncture also showed improve-
ment of CSF analysis.
HIV test, as well as immunologic screening for possi-
ble immunodeficiencies were negative.
The patient was treated with 4-drug regimen men-
tioned above for two months, followed by ten months of
isoniazid and rifampicin. Dexamethasone was added to
therapy for ten weeks. No toxic side effects of therapy
were noticed.
Chest x-ray showed complete resolution of nodules
two months after initiation of therapy, and brain MRI per-
formed six months after admission to hospital demonstrat-
ed no pathology. On follow-up one year later, the patient
was in good clinical condition and no neurological seque-
lae were reported.
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Figure 5. Brain MRI reveals significant reduction of the miliary tuberculomas 1 month after initiation of antituberculous therapy 
Slika 5. MR mozga pokazuje zna~ajnu redukciju milijarnih tuberkuloma mjesec dana nakon po~etka antituberkulotskog lije~enja
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Discussion
With an overall mortality rate of almost 15 % and per-
manent neurological sequelae occurring in around half of
patients, CNS TB remains a devastating infection in child-
hood [3].
Early recognition of CNS TB is difficult because clini-
cal and laboratory manifestations can mimic many infec-
tious and noninfectious diseases. Our patient presented
with 1-month history of occasional low-grade fever with
abdominal pain, diarrhea, cough and weight loss. Labora-
tory findings of elevated erythrocyte sedimentation rate
and slightly elevated transaminases were also nonspecific.
Children with CNS TB often initially present with ab-
dominal symptoms such as nausea and vomiting. The dis-
ease is typically subacute and progresses through three
phases:  the prodromal, meningitic and paralytic phase.
The prodromal phase, lasting two to three weeks, is char-
acterized by nonspecific symptoms such as malaise, lassi-
tude, headache or low-grade fever. The meningitic phase
follows with more pronounced neurologic features, such
as meningismus, protracted headache, vomiting, lethargy,
confusion, and cranial nerve and long-tract signs. The par-
alytic phase is characterized by confusion which progress-
es to stupor and coma, seizures, and often hemiparesis [3,
4].
The diagnosis of CNS TB was suspected in our patient
in meningitic phase, having in mind one-month history of
nonspecific symptoms and finding of small nodules on
chest x-ray performed on admission.
It's important to emphasize that abnormalities on chest
radiograph may be seen only in half of CNS TB cases,
ranging from focal lesions to a subtle miliary pattern [5].
Other sighs of active TB outside the CNS, such as choroid-
al tubercles, as seen in our patient, are of diagnostic import
if present. 
Although the typical analysis of CSF from patients
with CNS TB demonstrates lymphocytic pleocytosis, low
glucose level and elevated protein level, there are many
atypical presentations with normal protein or glucose level
or normal white blood cell count. There even may be a pre-
dominance of polymorphonuclear cells rather than lym-
phocytes in the CSF [6]. Similarly, CSF analysis of our pa-
tient wasn't typical for TB: mild pleocytosis with polymor-
phonuclear cell predominance (55 %), only slightly elevat-
ed protein level (0.83 g/L) and relative hypoglycorachia
(1.7 mmol/L or 35 % of blood glucose level).
Definitive diagnosis of CNS TB is based on the detec-
tion of the tubercle bacilli in the CSF, either by smear ex-
amination or by bacterial culture. However, the demon-
stration of mycobacteria in the CNS is not always possible.
It is known that the sensitivity of acid-fast staining and TB
culture of CSF is directly dependent on the number and
volume of CSF samples examined. That's why repeat lum-
bar puncture, meticulous microscopy and culture of a large
volume (> 6 mL) of CSF are recommended [7]. Unfortuna-
tely, mycobacteria weren't confirmed in CSF samples of
our patient, probably because one sample was taken on ad-
mission, and second three days later, when therapy was al-
ready initiated.
Because of the limitations of conventional tests, the
commercial nucleic acid amplification test and other PCR-
based assays have emerged as an alternative diagnostic
tool. The Xpert MTB/RIF used in this case is reported to
have sensitivity of almost 60 % in the diagnosis of CNS TB
[8].
We used blood IGRA as a supportive method for diag-
nosing CNS TB, although it is reported to have limited di-
agnostic value and negative results cannot entirely exclude
the disease. As with the tuberculin skin test, IGRAs cannot
distinguish latent tuberculosis infection from active dis-
ease. The sensitivity of IGRA assays in patients with mil-
iary tuberculosis is reported to be 68 – 93 % [9, 10].
CNS TB has various imaging appearances, including
meningitis, tuberculoma, miliary tuberculosis, abscess,
cerebritis and encephalopathy. Although meningitis is the
most common radiologic manifestation of CNS TB, seen
most frequently in the children and adolescents [11], our
patient's brain MRI didn't show signs of meningeal en-
hancement or other radiologic manifestations of possible
TB meningitis complications (progressive hydrocephalus,
vasculitis, infarction or cranial neuropathies) [12]. On the
contrary, MRI showed contrast-enhanced tiny lesions in
cerebrum, cerebellum and brainstem. This imaging sug-
gested the miliary pattern of intracranial tuberculomas,
rare parenchymal form of CNS TB, seen mostly in severe-
ly immunocompromised patients [13]. These lesions are
usually located at the corticomedullary junctions, are tiny
(2 – 3 mm in diameter) and may be invisible on noncon-
trast MR sequenced. Postcontrast, T1-weighted MR im-
ages reveal numerous, round, small, homogeneous, en-
hancing (usually ring enhancement) lesions [14].
Since our patient raised a high index of suspicion on
CNS TB, empiric antituberculous therapy with 4-drug reg-
imen was promptly initiated, with significant resolution of
symptoms and improvement of chest x-ray and brain MRI.
Dexamethasone was also added to therapy regimen as ad-
junctive therapy. Because of the relative rarity of TBM and
the difficulty of early diagnosis no randomized controlled
trial has established an optimal regimen and course for
CNS TB.  Nevertheless, our patient was treated with an ini-
tial 2-month induction therapy regimen including isoni-
azid, rifampicin, pyrazinamide and ethambutol, followed
by 10 additional months of isoniazid and rifampicin as
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maintenance therapy, as suggested by most guidelines
[15]. The use of steroid therapy as an adjunctive therapy is
also approved by guidelines, and the mechanism for sur-
vival benefit may come from reducing hydrocephalus and
preventing infarction [16].
Our patient recovered completely, without neurologic
sequelae. One of the reasons is early recognition and
prompt initiation of treatment. Namely, the overall mortal-
ity from CNS TB may be greater than 50 % in those pa-
tients recognized late in the course of disease. A large pro-
portion of these patients also suffer from severe sequelae
[3]. The other reason for good outcome is probably
Bacillus Calmette-Guérin (BCG) vaccine, which is a part
of national immunization program in Croatia and is given
to all newborns.  BCG is thought to be 52 – 86 % protective
against developing the severe complications of TB such as
miliary TB and CNS TB [17], but in cases of CNS TB it
protects against a fatal outcome and severe sequelae [3].
In conclusion, we reported a case of CNS TB with rare
form of miliary intracranial tuberculomas. Although the
etiology wasn't confirmed since the CSF cultures and acid-
fast stain remained negative, clinical presentation, epi-
demiological history, signs of TB outside the CNS and
good clinical and radiologic response to antituberculous
treatment indicated the diagnosis. 
CNS TB continues to be a condition which carries sig-
nificant morbidity and mortality. Early diagnosis and
prompt initiation of treatment are essential to improve the
poor outcome.
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